Trials / Completed
CompletedNCT04711837
Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery
A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 255 (actual)
- Sponsor
- Haisco-USA Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a multicenter, randomized, double-blinded, propofol-controlled, Phase 3 clinical study to evaluate the efficacy and safety of HSK3486 for induction of general anesthesia in adults undergoing elective surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK3486 | HSK3486 for induction of general anesthesia. |
| DRUG | Propofol | Propofol for induction of general anesthesia. |
Timeline
- Start date
- 2021-02-11
- Primary completion
- 2022-04-13
- Completion
- 2022-04-20
- First posted
- 2021-01-15
- Last updated
- 2025-10-10
- Results posted
- 2023-05-26
Locations
13 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04711837. Inclusion in this directory is not an endorsement.